Apothecary By Design is working closely with patients and healthcare providers to help them make full use of new therapies for hepatitis C, the most common chronic blood-borne infection in the United States.
Known as “the silent plague,” the disease has grown in prevalence—but its symptoms can take decades to appear. Liver damage caused by hepatitis C is the most common reason for liver transplantation in the U.S.
In the past, treatments for hepatitis C had limited success and were often poorly tolerated. But today, new medications are allowing people with hepatitis C to achieve outcomes that were impossible just a few years ago.
While these medications are generally well-tolerated and have a high potential for cure, unique reimbursement requirements and the need to follow a relatively brief but strict treatment regimen mean that patients need pharmacy support more than ever. ABD’s multidisciplinary clinical team helps empower each individual with hepatitis C so he or she can experience the best possible result from treatment.